Product Images Gocovri
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Gocovri NDC 17772-085 by Supernus Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemical structure - gocovri 01
PRINCIPAL DISPLAY PANEL - 68.5 mg Capsule Bottle Label - gocovri 02
This is a description of AADAMAS extended-release capsules containing 68.5 mg of amantadine hydrochloride USP equivalent to 85 mg. The capsules are manufactured for Adamas Operations, LLC based in Emeryville, CA. The product comes in packs of 60 capsules with GTIN 0317772085600. Instructions include storing the capsules at 20°C to 25°C and keeping them out of reach of children. For full prescribing information, refer to the package insert.*
PRINCIPAL DISPLAY PANEL - 137 mg Capsule Bottle Label - gocovri 03
This text appears to be a description for a medication called ADAMAS™ in the form of extended-release capsules containing 137 mg of amantadine. The capsules are manufactured by Adamas Operations, LLC in Emeryville, CA. Each capsule is equivalent to 170 mg of amantadine hydrochloride USP and is for prescription use only. The product comes in a pack of 60 capsules. It provides a TIN number as 0031772170603 and an NDC number 17772-170-60. The storage instructions recommend keeping it between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). For full prescribing information, it advises referring to the package insert and reminds to keep the medication out of reach of children.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
